AIM2 and psoriasis: We next analyzed a public GEO database (GSE117468) (23) to assess the relative expression of AIM2 mRNA in lesioned skin biopsies from patients with psoriasis who were treated with brodalumab, a human monoclonal antibody targeting the receptor subunit IL-17RA (24).